Written by Zachary Newland, Founding Partner. Last updated October 13, 2026.

Drug Diversion Allegations Against Nurses and Anesthesia Providers: Federal Criminal Exposure

On This Page

• What Drug Diversion Means in a Healthcare Workplace
• Federal Statutes That Apply to Drug Diversion
• How a Drug Diversion Investigation Unfolds
• Separate Tracks: Employer, Licensing Board, DEA, and Criminal
• What to Do After a Drug Diversion Accusation
• How Evergreen Attorneys Can Help
• Frequently Asked Questions

A nurse or anesthesia provider accused of drug diversion at work faces consequences that extend well beyond an employer write-up. Depending on the facts, a single accusation can trigger an internal investigation, a nursing license board investigation, a DEA inquiry, and a federal criminal prosecution, all at the same time and on separate tracks.

The federal penalties alone can include years in prison, loss of a professional license, and permanent exclusion from healthcare programs. If you are a healthcare professional confronting a drug diversion allegation, you need to understand how these proceedings work and what specific steps protect your rights.

Contact Evergreen Attorneys today at (303) 948-1489 if you are a healthcare worker facing a federal criminal investigation. You deserve a defense built on strategy and strength from day one.

What Drug Diversion Means in a Healthcare Workplace

Drug diversion occurs when a controlled substance or prescription medication is removed, used, transferred, or altered for a purpose not authorized by the prescription or treatment plan. In hospitals and surgical centers, common allegations involve removing medication from an automated dispensing cabinet without a valid order, falsifying waste records, substituting saline or another liquid for a controlled substance, or taking medication intended for a patient.

The CDC has warned that healthcare-provider diversion can expose patients to impaired care, denial of needed pain medication, and contamination risks from reused or tampered syringes. These patient-safety concerns are precisely what prompt employers, regulators, and federal agencies to act quickly once a discrepancy surfaces.

Federal Statutes That Apply to Drug Diversion

Nurse and anesthesia drug diversion allegations and cases involving anesthesia providers can implicate several federal criminal statutes. The three most relevant are:

1. 21 U.S.C. § 841 and the Controlled Substances Act: This statute prohibits knowingly or intentionally manufacturing, distributing, or dispensing a controlled substance, or possessing it with intent to do so, except as authorized. A healthcare worker who removes a controlled substance from a facility without authorization may face charges under this provision.
2. 21 U.S.C. § 843(a)(3): This statute prohibits obtaining, or attempting to obtain, a controlled substance by fraud, deceit, misrepresentation, or subterfuge. Prosecutors use this charge when the evidence suggests that a nurse or anesthesia provider used facility access to acquire controlled substances through deceptive means.
3. 18 U.S.C. § 1365: This is the federal tampering-with-consumer-products statute. Recent official DEA press releases involving alleged fentanyl diversion by an anesthesia nurse identified charges under this statute alongside 21 U.S.C. § 843(a)(3) in a case where the government alleged that an advanced practice nurse specializing in anesthesia replaced fentanyl vials with clear liquid.

Convictions under these statutes carry substantial prison sentences, fines, and mandatory loss of DEA registration or controlled-substance privileges.

Evergreen Attorneys wins 9-0 in the U.S. Supreme Court.

How a Drug Diversion Investigation Unfolds

A drug diversion investigation process typically begins when a facility identifies a discrepancy. Common triggers include:

• Automated dispensing cabinet records showing unusual withdrawal patterns
• Mismatches between medication pulled and documented waste
• Anesthesia-record discrepancies between doses charted and doses administered
• Patient complaints of inadequate pain relief despite recorded administration
• Witness reports or video surveillance

Once a discrepancy is flagged, the facility may interview the healthcare worker, restrict access to controlled substances, remove the person from patient-facing duties, or order a for-cause drug test under workplace policy. These are employer actions. They are not criminal findings, and they do not establish guilt.

A facility that holds a DEA registration may also have reporting obligations after a confirmed theft or significant loss of controlled substances. That report can prompt a separate DEA investigation. If the DEA or another federal agency develops evidence of criminal conduct, the matter may be referred to a United States Attorney’s Office for prosecution.

Separate Tracks: Employer, Licensing Board, DEA, and Criminal

One of the most dangerous misunderstandings for nurses and anesthesia providers facing drug diversion allegations is treating all proceedings as a single event. In reality, four separate tracks can run simultaneously:

1. Employer investigation: The facility investigates under its own policies, which may result in suspension, termination, or reporting to the state licensing board and DEA.
2. Nursing license board investigation: The board can open its own proceeding. Board outcomes (license suspension, revocation, or conditions) are independent of any criminal determination.
3. DEA administrative action: The DEA may investigate whether a registrant or authorized user violated the Controlled Substances Act or DEA regulations, including the security requirements in 21 C.F.R. § 1301.71(a) and § 1301.75.
4. Federal criminal prosecution: Federal prosecutors may bring charges based on evidence developed through the employer report, the DEA inquiry, or an independent investigation.

Statements made in an employer interview, a licensing-board proceeding, or a DEA interview can potentially be used in a federal criminal case. That overlap is why legal counsel should be involved before any substantive interview.

What to Do After a Drug Diversion Accusation

If you are a nurse or anesthesia provider accused of drug diversion, take the following steps:

1. Preserve all records. Do not alter, delete, backdate, or destroy medication logs, patient-care records, employment documents, text messages, or emails. Destruction of evidence in the face of a federal investigation can result in separate criminal charges.
2. Identify which entity is investigating. Determine whether the inquiry is coming from your employer, a state licensing board, the DEA, a federal agent, or some combination. Each body operates under different rules and carries different consequences.
3. Do not provide a substantive interview without counsel. Before you answer questions from an employer compliance officer, a licensing-board investigator, a DEA agent, or any law-enforcement officer, understand what protections you have and whether your answers can be used against you in another proceeding.
4. Obtain a copy of any for-cause drug test results and the applicable testing protocol. Testing procedures, chain-of-custody practices, and cut-off levels matter. A positive result is not the same as a criminal conviction.
5. Consult a federal defense lawyer before responding to a DEA subpoena or target letter. A DEA subpoena compliance obligation requires careful handling. Producing records without understanding the scope of a federal investigation can expose you to additional liability.
6. Do not assume an employment action is the end of the matter. Even if you resign, are terminated, or reach a settlement with your employer, federal authorities retain the ability to investigate and prosecute independently.

How Evergreen Attorneys Can Help

Evergreen Attorneys represents nurses, anesthesia providers, and other healthcare professionals facing federal criminal exposure from drug diversion allegations. The firm’s practice focuses exclusively on federal criminal defense. Founding Partner Zachary Newland has appeared as counsel of record in more than 130 federal cases since 2016.

Evergreen Attorneys can evaluate a drug diversion accusation across all four tracks: employer proceedings, licensing-board matters, DEA administrative inquiries, and federal criminal investigations. The firm assists with evidence preservation, interview strategy, healthcare fraud grand jury testimony and witness rights, controlled-substance charge analysis under federal controlled-substance exposure for nurse practitioners and other practitioners, and defense of charges brought under 21 U.S.C. §§ 841 and 843 or related federal healthcare fraud defense statutes.

Frequently Asked Questions

What is drug diversion in a healthcare workplace?

Drug diversion occurs when a prescription drug or controlled substance is taken, used, transferred, or altered for a purpose not authorized by the prescription or treatment plan. In a healthcare setting, examples can include removing medication from an automated dispensing cabinet without authorization, falsifying waste records, substituting another liquid for a controlled substance, or taking medication intended for a patient. The CDC warns that diversion can expose patients to impaired care, inadequate treatment, or contamination risks.

Can a nurse or anesthesia provider be criminally charged for alleged drug diversion?

Yes. Depending on the facts, federal prosecutors may bring charges under 21 U.S.C. § 841(a)(1), which addresses unauthorized knowing or intentional distribution or dispensing, or 21 U.S.C. § 843(a)(3), which addresses obtaining a controlled substance through fraud, misrepresentation, or subterfuge. An alleged substitution or tampering incident may also implicate 18 U.S.C. § 1365, the federal tampering-with-consumer-products statute. A 2026 DEA press release confirmed charges under both § 843(a)(3) and § 1365 against an anesthesia nurse alleged to have replaced fentanyl with clear liquid.

What happens during a drug diversion investigation involving a nurse or anesthesia provider?

A facility may review dispensing-cabinet records, medication-administration records, waste documentation, patient charts, access logs, and video or witness information. It may also interview the healthcare worker, restrict access to controlled substances, remove the person from patient-facing duties, or request a for-cause drug test. These employment actions are not criminal findings. A separate nursing license board investigation or federal inquiry may proceed on its own timeline.

What should a healthcare professional do after being accused of drug diversion at work?

Preserve all medication, employment, patient-care, and communication records without altering or destroying anything. Before participating in any substantive employer, licensing-board, DEA, or law-enforcement interview, determine which entity is investigating, your status in that proceeding, and whether your statements could be used in a different forum. Consulting a federal defense lawyer before making substantive statements helps protect your rights across every parallel proceeding.

When should a nurse or anesthesia provider involve federal defense counsel?

Involve federal defense counsel as soon as you learn that a DEA agent, FBI agent, or federal prosecutor has any involvement in the matter, or when you receive a federal subpoena, target letter, or any federal document. Even at the employer-investigation stage, consulting counsel early protects against inadvertent statements that could be used in a later federal proceeding. The earlier counsel is involved, the more effectively evidence, interview strategy, and exposure across all tracks can be managed.

 

If you are facing a federal drug diversion investigation or criminal charges related to controlled substances in a healthcare setting, contact Evergreen Attorneys at (303) 948-1489 for confidential case evaluation.